Table 3 Demographic overview of patient samples.

From: Increased prefrontal cortex interleukin-2 protein levels and shift in the peripheral T cell population in progressive supranuclear palsy patients

Brain

Origin

n

Sex

Age (mean ± SD)

RIN (mean ± SD)

PMI (mean ± SD)

DD (mean ± SD)

NC

6 BBH, 10 NBB

16

6M

10F

76.6 ± 10.9

5.2 ± 0.7

21.7 ± 20.9

 

PSP

13 BBH, 3 HV

16

12M

4F

73.6 ± 8.2

5.5 ± 2.4

31.2 ± 17.1

7.9 ± 3.1

p

  

0.080

0.198

0.420

0.131

 

PBMC

 

NC

BMDB

18

14M

4F

70.1 ± 6.4

   

PSP

BMDB

9

7M

2F

67.3 ± 7.9

  

7.3 ± 3.7

p

  

>0.999

0.336

   
  1. NC: Normal controls; PSP: Progressive supranuclear palsy; BBH: Bispebjerg Brain Bank; BMDB: Bispebjerg Movement Disorder Biobank; NBB: Netherlands Brain Bank; HV: Harvard Brain and Tissue Resource Center; M: Male; F: Female; RIN: RNA Integrity Number; PMI: Post-mortem interval; DD: Disease duration; PBMC: Peripheral blood mononuclear cells. Age and DD are shown in years, PMI is shown in hours. Age, RIN, PMI and DD are shown as mean ± standard deviation. DD is defined as time from first symptoms to death. P values for group differences are shown on the bottom.
Back to article page